Biomedical Engineering Reference
In-Depth Information
21. Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan
W, Huang CC, Johns SJ, Kawamoto M, et al. 2006. The human organic anion transporter
3 (OAT3; SLC22A8): genetic variation and functional genomics. Am J Physiol Renal
Physiol 290:F905-F912.
22. Fujita T, Brown C, Carlson EJ, Taylor T, de la Cruz M, Johns SJ, Stryke D, Kawamoto
M, Fujita K, Castro R, et al. 2005. Functional analysis of polymorphisms in the organic
anion transporter, SLC22A6 (OAT1). Pharmacogenet Genom 15:201-209.
23. Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M,
Kamakura S, Kitakaze M, Tomoike H, Saito Y, Sawada J. 2004. Fourteen novel single-
nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation trans-
porter (OCT2). Drug Metab Pharmacokinet 19:239-244.
24. Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ, Huang CC,
Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM. 2004. Functional and
genetic diversity in the concentrative nucleoside transporter, CNT1, in human popula-
tions. Mol Pharmacol 65:512-519.
25. Ho RH, Leake BF, Roberts RL, Lee W, Kim RB. 2004. Ethnicity-dependent polymor-
phism in Na
+
-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain crit-
ical for bile acid substrate recognition. J Biol Chem 279:7213-7222.
26. Honda T, Dan Y, Koyabu N, Ieiri I, Otsubo K, Higuchi S, Ohtani H, Sawada Y. 2002.
Polymorphism of MDR1 gene in healthy Japanese subjects: a novel SNP with an amino
acid substitution (Glu108Lys). Drug Metab Pharmacokinet 17:479-481.
27. Honjo Y, Morisaki K, Huff LM, Robey RW, Hung J, Dean M, Bates SE. 2002.
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2
(MXR/BCRP/ABCP1). Cancer Biol Ther 1:696-702.
28. Iida A, Saito S, Sekine A, Mishima C, Kondo K, Kitamura Y, Harigae S, Osawa S,
Nakamura Y. 2001. Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes
encoding three organic anion transporters, three organic anion-transporting polypeptides,
and three NADH:ubiquinone oxidoreductase flavoproteins. J Hum Genet 46:668-683.
29. Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y. 2002.
C421A polymorphism in the human breast cancer resistance protein gene is associated
with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther
1:611-616.
30. Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K. 2001. Polymorphism of the
ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.
Pharmacogenetics 11:175-184.
31. Itoda M, Saito Y, Soyama A, Saeki M, Murayama N, Ishida S, Sai K, Nagano M, Suzuki H,
Sugiyama Y, Ozawa S, Sawada J. 2002. Polymorphisms in the ABCC2 (cMOAT/MRP2)
gene found in 72 established cell lines derived from Japanese individuals: an association
between single nucleotide polymorphisms in the 5
-untranslated region and exon 28. Drug
Metab Dispos 30:363-364.
32. Itoda M, Saito Y, Komamura K, Ueno K, Kamakura S, Ozawa S, Sawada J. 2002. Twelve
novel single-nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with
ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet
17:566-571.
33. Itoda M, Saito Y, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Suzuki H,
Sugiyama Y, Ozawa S, Sawada J. 2003. Eight novel single-nucleotide polymorphisms in
Search WWH ::
Custom Search